Skip to main content
  • 2882 Accesses

Abstract

Extrapleural pneumonectomy (EPP) is a formidable surgical procedure performed on patients with limited life expectancy. Anesthetic management may contribute to containment of perioperative morbidity and mortality through the control of intraoperative physiologic disruptions and postoperative pain, and an appreciation of the associated postoperative complications to effect early intervention. Beyond standard anesthetic management issues for pneumonectomy, there exist a number of important “EPP-specific” anesthetic concerns. These include significantly greater blood loss, more delicate management of intravascular fluid and blood components, greater operative impairment of venous return, high probability of arrhythmias and greater potential for hemodynamic instability related to pericardial window and its patch. Common causes of hypotension during EPP include compression of the heart or great vessels by tumor or surgical pressure/retraction, blood loss and/or inadequate fluid resuscitation and thoracic epidural sympathetic blockade. No single anesthetic recipe is of proven superiority for either EPP or lung resection surgery in general. The priority for early extubation favors the use of short-acting modern inhalational and intravenous agents, with limited use of ­traditional parenteral narcotics. Thoracic epidural analgesia is widely employed intraoperatively to facilitate extubation at the conclusion of surgery by providing dense analgesia without depression of sensorium or respiratory drive. Fluid management remains a challenge due to the increased blood loss in EPP, hemodynamic instability, renal toxicity of chemotherapy agents, and the potential for exacerbation of acute lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976;31:15–24.

    Article  PubMed  CAS  Google Scholar 

  2. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138–46.

    Article  PubMed  Google Scholar 

  3. Tilleman TR, Richards WG, Zellos L, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg. 2009;138:405–11.

    Article  PubMed  Google Scholar 

  4. de Perrot M, McRae K, Anraku M, et al. Risk factors for major complications after extrapleural pneumonectomy for malignant pleural mesothelioma. Ann Thorac Surg. 2008;85:1206–10.

    Article  PubMed  Google Scholar 

  5. Harpole DH, Liptay MJ, DeCamp Jr MM, et al. Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg. 1996;61:977–82.

    Article  PubMed  CAS  Google Scholar 

  6. Opitz I, Kestenholz P, Lardinois D, et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2006;29:579–84.

    Article  PubMed  Google Scholar 

  7. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63. discussion 63–55.

    Article  PubMed  CAS  Google Scholar 

  8. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:3007–13.

    Article  PubMed  CAS  Google Scholar 

  9. de Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol. 2009;27:1413–8.

    Article  PubMed  Google Scholar 

  10. Hartigan PM, Ng JM. Anesthetic strategies for patients undergoing extrapleural pneumonectomy. Thorac Surg Clin. 2004;14:575–83, xi.

    Google Scholar 

  11. Ng JM, Hartigan PM. Anesthetic management of patients undergoing extrapleural pneumonectomy for mesothelioma. Curr Opin Anaesthesiol. 2008;21:21–7.

    Article  PubMed  Google Scholar 

  12. Zellos L, Christiani DC. Epidemiology, biologic behavior, and natural history of mesothelioma. Thorac Surg Clin. 2004;14:469–77, viii.

    Google Scholar 

  13. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960;17:260–71.

    PubMed  CAS  Google Scholar 

  14. Carbone M, Kratzke RA, Testa JR. The pathogenesis of mesothelioma. Semin Oncol. 2002;29:2–17.

    Article  PubMed  CAS  Google Scholar 

  15. Weder W, Opitz I, Stahel R. Multimodality strategies in malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:172–6.

    Article  PubMed  Google Scholar 

  16. Carroll N, Mohamed F, Sugarbaker P. Hyperthermic chemoperfusion, and postoperative chemotherapy: The National Cancer Institute and Washington Hospital Center experience. In: Pass H, Vogelzang N, Carbone M, editors. Malignant mesothelioma: advances in pathogenesis, diagnosis and translational therapies. New York: Springer; 2005. p. 732–54.

    Google Scholar 

  17. Lee JM, Sugarbaker DJ. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma and other diffuse pleural malignancies. In: Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L, editors. Adult chest surgery. New York: McGraw-Hill; 2009. p. 868–84.

    Google Scholar 

  18. Reilly Jr JJ. Evidence-based preoperative evaluation of candidates for thoracotomy. Chest. 1999;116:474S–6.

    Article  PubMed  Google Scholar 

  19. Amar D, Burt ME, Roistacher N, et al. Value of perioperative Doppler echocardiography in patients undergoing major lung resection. Ann Thorac Surg. 1996;61:516–20.

    Article  PubMed  CAS  Google Scholar 

  20. Gill RR, Gerbaudo VH, Sugarbaker DJ, Hatabu H. Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg. 2009;21:111–20.

    Article  PubMed  Google Scholar 

  21. Slinger P. Update on anesthetic management for pneumonectomy. Curr Opin Anaesthesiol. 2009;22:31–7.

    Article  PubMed  Google Scholar 

  22. Wittnich C, Trudel J, Zidulka A, Chiu RC. Misleading “pulmonary wedge pressure” after pneumonectomy: its importance in postoperative fluid therapy. Ann Thorac Surg. 1986;42:192–6.

    Article  PubMed  CAS  Google Scholar 

  23. Brister NW, Barnette RE, Kim V, Keresztury M. Anesthetic considerations in candidates for lung volume reduction surgery. Proc Am Thorac Soc. 2008;5:432–7.

    Article  PubMed  Google Scholar 

  24. Ballantyne JC, Carr DB, deFerranti S, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998;86:598–612.

    PubMed  CAS  Google Scholar 

  25. Beattie WS, Badner NH, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg. 2001;93:853–8.

    Article  PubMed  CAS  Google Scholar 

  26. Oka T, Ozawa Y, Ohkubo Y. Thoracic epidural bupivacaine attenuates supraventricular tachyarrhythmias after pulmonary resection. Anesth Analg. 2001;93:253–9.

    PubMed  CAS  Google Scholar 

  27. Nino M, Body SC, Hartigan PM. The use of a bronchial blocker to rescue an ill-fitting double-lumen endotracheal tube. Anesth Analg. 2000;91:1370–1.

    Article  PubMed  CAS  Google Scholar 

  28. Slinger P. Pro: low tidal volume is indicated during one-lung ventilation. Anesth Analg. 2006;103:268–70.

    Article  PubMed  Google Scholar 

  29. Hurford WE, Kolker AC, Strauss HW. The use of ventilation/perfusion lung scans to predict oxygenation during one-lung anesthesia. Anesthesiology. 1987;67:841–4.

    Article  PubMed  CAS  Google Scholar 

  30. Bakaeen F, Rice D, Correa AM, et al. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg. 2007;84:982–6.

    Article  PubMed  Google Scholar 

  31. Slinger PD. Perioperative fluid management for thoracic surgery: the puzzle of postpneumonectomy pulmonary edema. J Cardiothorac Vasc Anesth. 1995;9:442–51.

    Article  PubMed  CAS  Google Scholar 

  32. Passman RS, Gingold DS, Amar D, et al. Prediction rule for atrial fibrillation after major noncardiac thoracic surgery. Ann Thorac Surg. 2005;79:1698–703.

    Article  PubMed  Google Scholar 

  33. Roselli EE, Murthy SC, Rice TW, et al. Atrial fibrillation complicating lung cancer resection. J Thorac Cardiovasc Surg. 2005;130:438–44.

    Article  PubMed  Google Scholar 

  34. Amar D, Roistacher N, Burt ME, et al. Effects of diltiazem versus digoxin on dysrhythmias and cardiac function after pneumonectomy. Ann Thorac Surg. 1997;63:1374–81. discussion 1372–81.

    PubMed  CAS  Google Scholar 

  35. Amar D, Roistacher N, Rusch VW, et al. Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery. J Thorac Cardiovasc Surg. 2000;120:790–8.

    Article  PubMed  CAS  Google Scholar 

  36. Dunning J, Treasure T, Versteegh M, Nashef SA. Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. Eur J Cardiothorac Surg. 2006;30:852–72.

    Article  PubMed  Google Scholar 

  37. Brown MJ, Brown DR. Thoracic cavity irrigation: an unusual cause of acute ST segment increase. Anesth Analg. 2002;95:552–4.

    PubMed  Google Scholar 

  38. Obata H, Saito S, Fujita N, et al. Epidural block with mepivacaine before surgery reduces long-term post-thoracotomy pain. Can J Anaesth. 1999;46:1127–32.

    Article  PubMed  CAS  Google Scholar 

  39. Senturk M, Ozcan PE, Talu GK, et al. The effects of three different analgesia techniques on long-term postthoracotomy pain. Anesth Analg. 2002;94:11–5.

    Article  PubMed  Google Scholar 

  40. Suzuki M, Haraguti S, Sugimoto K, et al. Low-dose intravenous ketamine potentiates epidural analgesia after thoracotomy. Anesthesiology. 2006;105:111–9.

    Article  PubMed  CAS  Google Scholar 

  41. Wolf AS, Daniel J, Sugarbaker DJ. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg. 2009;21:132–48.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Ng, JM. (2011). Extrapleural Pneumonectomy. In: Slinger, MD, FRCPC, P. (eds) Principles and Practice of Anesthesia for Thoracic Surgery. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0184-2_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-0184-2_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-0183-5

  • Online ISBN: 978-1-4419-0184-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics